Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?

Area of Science:

• Genetics
• Urology
• Molecular Biology

Background:

• Benign prostatic hyperplasia (BPH) is a common condition in aging men.
• Lower urinary tract symptoms (LUTS) are a primary manifestation of BPH.
• The role of genetic factors, such as angiotensin-converting enzyme (ACE) gene polymorphisms, in BPH pathogenesis is under investigation.

Purpose of the Study:

• To investigate the potential association between the ACE insertion/deletion (I/D) polymorphism and the occurrence of LUTS in patients with BPH.
• To determine if ACE gene variants influence the severity or presence of LUTS in BPH.

Main Methods:

• Genotyping for ACE I/D polymorphism using polymerase chain reaction (PCR) in 200 BPH patients with LUTS and 200 controls.
• Quantification of ACE levels via spectrophotometry.
• Statistical analysis using logistic regression models to assess genetic associations.

Main Results:

• No significant differences were observed in genotype distribution, allelic frequency, or carriage rate of ACE I/D polymorphism between BPH patients with LUTS and the control group.
• The study found no statistically significant correlation between ACE I/D polymorphism and the presence of LUTS in BPH.

Conclusions:

• The ACE I/D polymorphism does not appear to be a significant risk factor for LUTS in the studied population with BPH.
• Larger cohort studies are recommended to elucidate the potential role of ACE in BPH pathophysiology, considering cellular mechanisms and ethnic variations.